Nextleaf Solutions Ltd C.OILS

Back to Basics

[Adventurous]

This board is getting really interesting. Real investment questions are asked, but answers remain somewhat speculative. Members looking for tangible answers should look at "old" investment reports daring back to the time before Covid. Not everything has changed.

You should try running in your internet search engine the words: Ubika Alpha Nextleaf

So before Covid put the world upside down, it was estimated that Nextleaf was to get 14-15 million annually in sales from its vaping business, etc. You don't have to take the stock price target of $1.75 a share too seriously,,, but future still looks bright.

[shneps]

If you take anything related to Ubika Alpha back then and apply to any company today you would be soooo far underwater you'd never get out. All the reason I never invested in cannabis before this year. Those numbers were always far fetched.

[Adventurous]

On September 14, I was pointing to an investment report Ubika Alpha did in May 2019 on Nextleaf with a target price of $1,65 a share. It was based among other things on a profit margin of $7-$10 a vape cartridge. Nextleaf has done further progress since then (toll sales, IP, State B), but the general picture is pretty much the same. Can't wait for new investors to read updated versions of such

[Buyhigheatchips]

I think many of us would like to forget those Ubika reports. This stock will only advance on fundamentals or a major partnership on drug development (or a buyout).